oral glp-1 medications Orforglipron Is Approved for Obesity Eli Lilly Gets Speedy FDA

In recent years, GIP/GLP-1 receptor dual agonists and GIP/GLP-1/glucagon receptor triple agonists, which co-stimulate multiple hormone receptors including GIPR, continue to be reported to exert remarkable anti-obesity and hypoglycaemic effects when compared to agonists of the GLP-1R alone, and are now being applied in clinical practice

10.1055/s-2004-826160

GLP-1 Microdosing, Brain Health, and Alzheimers Prevention: What the Evidence Actually Shows AI Overview GLP-1 medications such as semaglutide and tirzepatide are being studied for more than weight loss

1992, Song et al

This is one of the most common and most dangerous points of confusion in the entire GLP-1 space